ChronicPseudomonas Aeruginosalung Infection is IL-1R Independent, but Relies on MyD88 Signaling
Claire Mackowiak,Tiffany Marchiol,Hana Cipcic Paljetak,Louis Fauconnier,Jennifer Palomo,Thomas Secher,Corinne Panek,Delphine Sedda,Florence Savigny,Francois Erard,Alessandra Bragonzi,Francois Huaux,Tobias Stoeger,Herbert B Schiller,Jean-Claude Sirard,Marc Le Bert,Isabelle Couillin,Valerie F J Quesniaux,Dieudonnée Togbe,Bernhard Ryffel
DOI: https://doi.org/10.4049/immunohorizons.2000095
2021-01-01
ImmunoHorizons
Abstract:Cystic fibrosis is associated with chronic Pseudomonas aeruginosa colonization and inflammation. The role of MyD88, the shared adapter protein of the proinflammatory TLR and IL-1R families, in chronic P. aeruginosa biofilm lung infection is unknown. We report that chronic lung infection with the clinical P. aeruginosa RP73 strain is associated with uncontrolled lung infection in complete MyD88-deficient mice with epithelial damage, inflammation, and rapid death. Then, we investigated whether alveolar or myeloid cells contribute to heightened sensitivity to infection. Using cell-specific, MyD88-deficient mice, we uncover that the MyD88 pathway in myeloid or alveolar epithelial cells is dispensable, suggesting that other cell types may control the high sensitivity of MyD88-deficient mice. By contrast, IL-1R1-deficient mice control chronic P. aeruginosa RP73 infection and IL-1β Ab blockade did not reduce host resistance. Therefore, the IL-1R1/MyD88 pathway is not involved, but other IL-1R or TLR family members need to be investigated. Our data strongly suggest that IL-1 targeted neutralizing therapies used to treat inflammatory diseases in patients unlikely reduce host resistance to chronic P. aeruginosa infection.